Companies

Explore all the available companies. Are you wondering how to find wonderful businesses at great price? Start from A... or take a look at Compoundeer Ranking.

  1. Bicara Therapeutics Inc.

    Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, or HNSCC, where there remains a significant unmet need. We intend to initiate a pivotal Phase 2/3 trial of ficerafusp alfa in combination with pembrolizumab as a first-line therapy in recurrent/metastatic HNSCC excluding HPV-positive patients with oropharyngeal squamous cell carcinoma late in the fourth quarter of 2024 or early in the first quarter of 2025.

    BCAX
  2. Bicycle Therapeutics Plc

    Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need.

    BCYC
  3. Big 5 Sporting Goods Corp

    Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.

    BGFV
  4. Big Lots Inc

    Big Lots Inc is principally engaged in operating discount retail stores. The company provides a broad range of merchandise, including food, consumables, soft home products, hard home products, furniture, electronics and accessories, and seasonal products. The company sources the merchandise from traditional and close-out channels. In addition to merchandise, the company sells gift cards, issues merchandise credits, and more. The company operates stores throughout the United States, with around one-third of its stores in California, Texas, Ohio, and Florida.

    BIGGQ
  5. Big Tree Cloud Holdings Ltd

    As of June 6, 2024, Plutonian Acquisition Corp. was acquired by Big Tree Cloud International Group Limited, in a reverse merger transaction. Plutonian Acquisition Corp. does not have significant operations. The company focuses on entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire businesses on companies engaged in metaverse technologies, tourism, and e-commerce related industries in the Asia-Pacific region. Plutonian Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

    DSY
  6. Bigbear.ai Holdings, Inc.

    BigBear.ai Holdings Inc is engaged in decision dominance serving the national defense and intelligence communities. It operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. The company uses its proprietary AI/ML technology to support its customer's decision-making processes and deliver practical solutions that work in complex, realistic, and imperfect data environments.

    BBAI
  7. Bigcommerce Holdings, Inc.

    BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems.

    BIGC
  8. Biglari Holdings Inc.

    No description

    BH-A
  9. Bilibili Inc.

    Bilibili is a Chinese online entertainment platform that is best known for its video-sharing site that resembles YouTube. The site was founded in 2009 and started as a long-form video platform for anime, comics, and gaming, or ACG, content that appealed to Gen Z users. Since then, it has expanded its content on the platform to include a broader range of interests that have attracted Chinese users outside of the Gen Z cohort. The firm generates revenue through five main areas: advertising, mobile games, live streaming, value-added services, and e-commerce.

    BILI
  10. Bill Holdings, Inc.

    Bill.com Holdings Inc is a provider of cloud-based software which automates complex back-office financial operations for SMBs. Its artificial-intelligence enabled financial software platform used mostly to build connections between customers, suppliers, and clients. The company's platform generates and process invoices, streamline approvals, send and receive payments, sync with their accounting system, and manage their cash. The firm generates revenue through subscription and transaction fees.

    BILL
  11. Bimergen Energy Corp

    Bimergen Energy Corporation [OTCQB: BESS] is a utility-scale Battery Energy Storage System (BESS) asset owner, project developer, and independent power provider focused on delivering critical power grid stability and reducing energy price volatility. The Company owns 23 development stage BESS projects with a cumulative energy capacity of estimated 2 gigawatts (GW). The company secures project financing and oversees construction of their energy storage projects, while operating partners and institutional counterparties will manage daily energy trading operations under long-term offtake agreements ensuring stable, contract-backed revenue. The company also owns 13 development stage solar energy projects with an anticipated cumulative generation capacity of 1.640 gigawatts (GW).

    BESS
  12. Bimini Capital Management, Inc.

    Bimini Capital Management Inc collectively with its subsidiaries functions in the financial services domain in the United States. As a real estate investment trust, the company follows the strategy of investing in mortgage-backed securities of two kinds, namely; traditional pass-through Agency Mortgage-backed securities and structured Agency Mortgage-backed securities.

    BMNM
  13. Binah Capital Group, Inc.

    Binah Capital Group, Inc. is an independent wealth management company. The Company operates, through its subsidiary, Wentworth Management Services LLC (Wentworth). Wentworth is engaged in acquiring and managing businesses in the wealth management industry. The Company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in technology-enabled regulatory environment. Wentworth focuses on building long-term, productive relationships with its advisor base. Wentworth owns and operates 10 entities, four of which are broker-dealers, three of which are registered investment advisors, and three of which are insurance entities located in 535 offices in all 50 states. The Company also includes a dealer manager business, investment banking division and a wholesale distribution division. In addition, the Company owns three registered investment advisors and two general agencies.

    BCG
  14. Bingex Ltd

    BingEx Ltd. operates as a non-classified establishment. It intends to provide courier services. The company was founded by Peng Xue and Hongjian Yu in May 2014 and is headquartered in Beijing, China.

    FLX
  15. Bio Essence Corp

    Bio Essence Corp develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offers special formulated dietary supplements and medical food.

    BIOE
  16. Bio Key International Inc

    BIO-key International Inc is a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

    BKYI
  17. Bio-path Holdings, Inc.

    Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003.

    BPTH
  18. Bio-rad Laboratories, Inc.

    Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

    BIO
  19. Bio-techne Corp

    Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

    TECH
  20. Bioadaptives, Inc.

    BioAdaptives Inc is engaged in developing research-based clinically validated natural wellness solutions. The firm focuses on the research of primitive cells like stem cells and their derivatives. Its products include dietary supplements, specialty food items, and proprietary methods of optimizing the bioelectromagnetic availability of foods and beverages. Its product lines include PrimiCell, a primitive cell activator, PrimiLungs, a lung immune defense product, and PluriPain.

    BDPT
  21. Bioaffinity Technologies, Inc.

    bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.

    BIAF
  22. Bioage Labs, Inc.

    BioAge Labs is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Our technology platform and differentiated human datasets enable us to identify promising targets based on insights into molecular changes that drive aging. Azelaprag, our lead product candidate, demonstrated the ability to more than double the weight loss induced by a glucagon-like-peptide-1 receptor (GLP-1R) agonist while also restoring healthy body composition and improving muscle function in preclinical obesity models. These preclinical results are supported by our Phase 1b clinical trial in older adults on bed rest where we observed decreased muscle atrophy, preservation of muscle quality and improved metabolism in subjects treated with azelaprag over a 10-day period.

    BIOA
  23. Bioatla, Inc.

    BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs.

    BCAB
  24. Biocardia, Inc.

    BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

    BCDA
  25. Bioceres Crop Solutions Corp.

    Bioceres Crop Solutions Corp is a fully-integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. The business divisions consist of crop protection, seed and integrated products, and crop nutrition. Its product includes fertilizers, inoculants, adjuvants, crop protection solutions and seeds.

    BIOX
  26. Biocorrx Inc.

    BioCorRx Inc is an alcohol treatment and rehabilitation company. It is engaged in the development of BioCorRx Recovery Program for the treatment of alcoholism and opioid addiction consisting of a naltrexone implant. It operates within the Specialty Hospitals, Expert Psychiatric industry, specifically within the industry subsets of Alcoholism Rehabilitation Hospital. The BioCorRx Recovery Program is a non-addictive, medication-assisted treatment program used to treat both alcohol and opioid addictions.

    BICX
  27. Biocryst Pharmaceuticals Inc

    BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

    BCRX
  28. Biodesix Inc

    Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

    BDSX
  29. Biodexa Pharmaceuticals Plc

    Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs. The Company's lead development programs include eRapa, in Phase 3 development for Familial Adenomatous Polyposis; tolimidone, in Phase 2 development for the treatment of type 1 diabetes; and MTX110, in Phase 1 development in aggressive rare/orphan brain cancer indications.

    BDRX
  30. Bioforce Nanosciences Holdings, Inc.

    BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing.

    BFNH